In my opinion, blinded aggregate data can be very informative.  I think this issue has been discussed here before, but aggregate data can tell us a LOT!  MACE rates, changes in certain biomarkers, and many other data points can be compared to "expected" and/or "placebo expected" several different ways.  One has to careful about trying to draw conclusions, but aggregate results are at the very least directional.